Centre for Chronic Disease Control, New Delhi, India.
Hubert Department of Global Health, Emory University, Atlanta, GA, United States.
Front Public Health. 2023 Mar 27;11:1108465. doi: 10.3389/fpubh.2023.1108465. eCollection 2023.
Studies have highlighted a possible influence of gingival and periodontal disease (PD) on COVID-19 risk and severity. However, the evidence is based on hospital-based studies and community-level data are sparse.
We described the epidemiological pattern of SARS-CoV-2 infection in Delhi and evaluated the associations of gingival and PD with incident COVID-19 disease in a regionally representative urban Indian population.
In a prospective study nested within the Centre for Cardiometabolic Risk Reduction in South-Asia (CARRS) study, participants with clinical gingival and periodontal status available at baseline (2014-16) ( = 1,727) were approached between October 2021 to March 2022. Information on COVID-19 incidence, testing, management, severity was collected as per the WHO case criteria along with COVID-19 vaccination status. Absolute incidence of COVID-19 disease was computed by age, sex, and oral health. Differences in rates were tested using log-rank test. Poisson regression models were used to evaluate independent associations between gingival and PD and incidence of COVID-19, adjusted for socio-demographic and behavioral factors, presence of comorbidity, and medication use.
Among 1,727 participants, the mean age was 44.0 years, 45.7% were men, 84.5% participants had baseline gingival or PD and 89.4% participants had received at least one dose of COVID-19 vaccine. Overall, 35% ( = 606) participants were tested for COVID-19 and 24% ( = 146/606) tested positive. As per the WHO criteria total number of cases was 210, constituting 12% of the total population. The age and sex-specific rates of COVID-19 were higher among men and older participants, but women aged >60 years had higher rates than men of same age. The incidence rate did not differ significantly between those having gingival or PD and healthy periodontium (19.1 vs. 16.5/1,000 person-years) and there was no difference in risk of COVID-19 by baseline oral disease status.
Gingival and PD were not associated with increased risk of COVID-19.
研究强调了牙龈和牙周疾病(PD)对 COVID-19 风险和严重程度的可能影响。然而,这些证据基于医院研究,社区层面的数据很少。
我们描述了德里地区 SARS-CoV-2 感染的流行病学模式,并评估了在一个具有地区代表性的印度城市人群中,牙龈和 PD 与 COVID-19 疾病发病的相关性。
在南亚心脏代谢风险降低中心(CARRS)研究中进行的一项前瞻性研究中,对基线时具有临床牙龈和牙周状况的参与者(2014-16 年)( = 1727)进行了研究。在 2021 年 10 月至 2022 年 3 月期间,收集了 COVID-19 发病率、检测、管理和严重程度的信息,以及 COVID-19 疫苗接种状况。按照世界卫生组织的病例标准,根据年龄、性别和口腔健康计算 COVID-19 疾病的绝对发病率。使用对数秩检验测试差异。使用泊松回归模型,在调整社会人口统计学和行为因素、合并症的存在以及药物使用的情况下,评估牙龈和 PD 与 COVID-19 发病的独立相关性。
在 1727 名参与者中,平均年龄为 44.0 岁,45.7%为男性,84.5%的参与者基线时患有牙龈或 PD,89.4%的参与者至少接种了一剂 COVID-19 疫苗。总体而言,35%( = 606)的参与者接受了 COVID-19 检测,24%( = 146/606)检测呈阳性。根据世界卫生组织的标准,总病例数为 210 例,占总人数的 12%。在男性和年龄较大的参与者中,COVID-19 的年龄和性别特异性发病率较高,但年龄>60 岁的女性比同龄男性的发病率更高。牙龈或 PD 与健康牙周病的 COVID-19 发病率没有显著差异(19.1 与 16.5/1000 人年),基线口腔疾病状况与 COVID-19 风险无差异。
牙龈和 PD 与 COVID-19 风险增加无关。